This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Age and oesophageal cancer

Authoring team

  • 99% of cases of upper gastrointestinal cancer (oesophagus, stomach, pancreas) occur over in patients over 40 years old
  • over 90% of gastric cancers occur in patients over 55 years old
    • incidence is strongly related to age, with the highest incidence rates being in older men and women. In the UK between 2009 and 2011, an average of 51% cases were diagnosed in men and women aged 75 and over

  • with respect to stomach cancer:
    • age-specific incidence rates rise sharply from around age 60-64, peak in the 85-89 age group, and subsequently drop in those aged 90+. Incidence rates are higher for males than for females in those aged 40-44 and over (in the younger age groups the sex difference is not significant) and this gap is widest at the ages of 65 to 69, when the male:female incidence ratio of age-specific rates (to account for the different proportions of males to females in each age group) is around 28:10

  • with respect to oesophageal cancer:
    • age-specific incidence rates rise sharply from around age 45-49 years, with the highest rates in the 90+ age group (2)
      • incidence rates are higher for males than females from age 30-34, with no significant differences at younger ages
      • gap is widest at the ages of 40-44, when the male:female ratio of age-specific incidence rates (to account for the different proportions of males to females in each age group) is around 37:10

Reference:


Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.